This report describes and explains the bioprocess automation market and covers 2020-2025, termed the historic period, and 2025-2030, 2035F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global bioprocess automation market reached a value of nearly $6.36 billion in 2025, having grown at a compound annual growth rate (CAGR) of 13.2% since 2020. The market is expected to grow from $6.36 billion in 2025 to $11.46 billion in 2030 at a rate of 12.5%. The market is then expected to grow at a CAGR of 12% from 2030 and reach $20.24 billion in 2035.
Growth in the historic period resulted from growing demand for personalized medicine, rising global demand for biologics, growth of cell and gene therapies and shortage of skilled workforce. Factors that negatively affected growth in the historic period were data security and cybersecurity concerns and limited standardization across platforms.
Going forward, increasing prevalence of chronic diseases, expansion of contract development and manufacturing organizations (CDMOs) and outsourcing, rising investments in biotech research and development (R&D) and expansion of vaccine production will drive the growth. Factors that could hinder the growth of the bioprocess automation market in the future include high capital investment requirement, complexity in system integration and impact of trade war and tariff.
Market trends for the bioprocess automation market include integration of artificial intelligence and machine learning in bioprocess control, innovative gradient maker improves quality and reliability in purification, ai-driven multi-channel biosensing transforming real-time bioprocess monitoring and optimization, intelligent cell processing system improves production quality and safety, next-level bioprocess development system optimizes process control and increasing use of distributed control systems (DCS) for complex bioprocess management.
The bioprocess automation market is segmented by component of process control system into sensors, actuators and controllers. The controllers market was the largest segment of the bioprocess automation market segmented by component of process control system, accounting for 39.9% or $2.53 billion of the total in 2025. Going forward, the sensors segment is expected to be the fastest-growing segment in the bioprocess automation market segmented by component of process control system, at a CAGR of 13.8% during 2025-2030.
The bioprocess automation market is segmented by scale of operation into preclinical operations, clinical operations and commercial operations. The commercial operations was the largest segment of the bioprocess automation market segmented by scale of operation, accounting for 65.7% or $4.17 billion of the total in 2025. Going forward, the preclinical operations segment is expected to be the fastest-growing segment in the bioprocess automation market segmented by scale of operation, at a CAGR of 14% during 2025-2030.
The bioprocess automation market is segmented by mode of operation into batch, fed-batch and perfusion. The fed-batch market was the largest segment of the bioprocess automation market segmented by mode of operation, accounting for 46.5% or $2.96 billion of the total in 2025. Going forward, the perfusion segment is expected to be the fastest-growing segment in the bioprocess automation market segmented by mode of operation, at a CAGR of 18.7% during 2025-2030.
The bioprocess automation market is segmented by compatibility with bioprocessing systems into single-use systems, stainless steel and other bioprocessing systems. The single-use systems market was the largest segment of the bioprocess automation market segmented by compatibility with bioprocessing systems, accounting for 46.4% or $2.95 billion of the total in 2025. Going forward, the single-use systems segment is expected to be the fastest-growing segment in the bioprocess automation market segmented by compatibility with bioprocessing systems, at a CAGR of 15.9% during 2025-2030.
North America was the largest region in the bioprocess automation market, accounting for 42% or $2.67 billion of the total in 2025. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the bioprocess automation market will be Asia Pacific and Middle Eastwhere growth will be at CAGRs of 14% and 13.5% respectively. These will be followed by North America and South America where the markets are expected to grow at CAGRs of 12% and 11.9% respectively.
The global bioprocess automation market is fairly fragmented, with a large number of small players operating in the market. The top 10 competitors in the market made up 19.55% of the total market in 2024. Thermo Fisher Scientific Inc. was the largest competitor with a 3.40% share of the market, followed by Danaher Corporation (Cytia) with 2.38%, Sartorius AG with 2.05%, Lonza Group AG with 2.03%, Merck KGaA (MilliporeSigma), with 1.88%, F. Hoffmann-La Roche Ltd. with 1.81%, Siemens AG with 1.59%, Rockwell Automation Inc. with 1.54%, Emerson Electric Co. with 1.50% and Waters Corporation with 1.37%.
The top opportunities in the bioprocess automation market segmented by component of process control system will arise in the sensors segment, which will gain $2.01 billion of global annual sales by 2030. The top opportunities in the bioprocess automation market segmented by scale of operation will arise in the commercial operations segment, which will gain $3.2 billion of global annual sales by 2030. The top opportunities in the bioprocess automation market segmented by mode of operation will arise in the fed-batch segment, which will gain $2.55 billion of global annual sales by 2030. The top opportunities in the bioprocess automation market segmented by compatibility with bioprocessing systems will arise in the single-use systems segment, which will gain $3.21 billion of global annual sales by 2030. The bioprocess automation market size will gain the most in the USA at $1.86 billion.
Player-adopted strategies in the bioprocess automation market include focuses on expanding their business expertise through strategic partnerships, expanding its operational capabilities through new launches, expanding its operational capabilities through new facilities, enhancing its business operations through new product developments.
Market-trend-based strategies for the bioprocess automation market include focus on integrating artificial intelligence (AI) and machine learning (ML) into bioprocess control systems to enable predictive modelling, automated gradient dispensing, which minimizes manual errors in purification. These systems precisely control the delivery of solvents, leveraging AI-driven technologies and multi-channel biosensing platforms to improve production efficiency, intelligent cell processing system improves production quality and safety and adopting distributed control systems (DCS) to manage complex bioprocessing workflows, enabling centralized supervision.
To take advantage of the opportunities, the analyst recommends the bioprocess automation companies to focus on ai-driven bioprocess control integration, focus on ai-enabled multi-channel biosensing platforms, focus on intelligent closed-loop cell processing systems, focus on high-throughput automated bioprocess development platforms, focus on distributed control systems for integrated bioprocess automation, focus on fastest growing sensors segment in bioprocess automation, focus on preclinical operations in bioprocess automation, focus on perfusion-based continuous bioprocess automation, expand in emerging markets, focus on hybrid distribution networks for bioprocess automation expansion, focus on value based and modular pricing strategies in bioprocess automation, focus on digital first technical promotion and thought leadership, focus on strategic industry partnerships and event driven promotion, focus on single-use systems for scalable bioprocess automation.
This product will be delivered within 3-5 business days.
The global bioprocess automation market reached a value of nearly $6.36 billion in 2025, having grown at a compound annual growth rate (CAGR) of 13.2% since 2020. The market is expected to grow from $6.36 billion in 2025 to $11.46 billion in 2030 at a rate of 12.5%. The market is then expected to grow at a CAGR of 12% from 2030 and reach $20.24 billion in 2035.
Growth in the historic period resulted from growing demand for personalized medicine, rising global demand for biologics, growth of cell and gene therapies and shortage of skilled workforce. Factors that negatively affected growth in the historic period were data security and cybersecurity concerns and limited standardization across platforms.
Going forward, increasing prevalence of chronic diseases, expansion of contract development and manufacturing organizations (CDMOs) and outsourcing, rising investments in biotech research and development (R&D) and expansion of vaccine production will drive the growth. Factors that could hinder the growth of the bioprocess automation market in the future include high capital investment requirement, complexity in system integration and impact of trade war and tariff.
Market trends for the bioprocess automation market include integration of artificial intelligence and machine learning in bioprocess control, innovative gradient maker improves quality and reliability in purification, ai-driven multi-channel biosensing transforming real-time bioprocess monitoring and optimization, intelligent cell processing system improves production quality and safety, next-level bioprocess development system optimizes process control and increasing use of distributed control systems (DCS) for complex bioprocess management.
The bioprocess automation market is segmented by component of process control system into sensors, actuators and controllers. The controllers market was the largest segment of the bioprocess automation market segmented by component of process control system, accounting for 39.9% or $2.53 billion of the total in 2025. Going forward, the sensors segment is expected to be the fastest-growing segment in the bioprocess automation market segmented by component of process control system, at a CAGR of 13.8% during 2025-2030.
The bioprocess automation market is segmented by scale of operation into preclinical operations, clinical operations and commercial operations. The commercial operations was the largest segment of the bioprocess automation market segmented by scale of operation, accounting for 65.7% or $4.17 billion of the total in 2025. Going forward, the preclinical operations segment is expected to be the fastest-growing segment in the bioprocess automation market segmented by scale of operation, at a CAGR of 14% during 2025-2030.
The bioprocess automation market is segmented by mode of operation into batch, fed-batch and perfusion. The fed-batch market was the largest segment of the bioprocess automation market segmented by mode of operation, accounting for 46.5% or $2.96 billion of the total in 2025. Going forward, the perfusion segment is expected to be the fastest-growing segment in the bioprocess automation market segmented by mode of operation, at a CAGR of 18.7% during 2025-2030.
The bioprocess automation market is segmented by compatibility with bioprocessing systems into single-use systems, stainless steel and other bioprocessing systems. The single-use systems market was the largest segment of the bioprocess automation market segmented by compatibility with bioprocessing systems, accounting for 46.4% or $2.95 billion of the total in 2025. Going forward, the single-use systems segment is expected to be the fastest-growing segment in the bioprocess automation market segmented by compatibility with bioprocessing systems, at a CAGR of 15.9% during 2025-2030.
North America was the largest region in the bioprocess automation market, accounting for 42% or $2.67 billion of the total in 2025. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the bioprocess automation market will be Asia Pacific and Middle Eastwhere growth will be at CAGRs of 14% and 13.5% respectively. These will be followed by North America and South America where the markets are expected to grow at CAGRs of 12% and 11.9% respectively.
The global bioprocess automation market is fairly fragmented, with a large number of small players operating in the market. The top 10 competitors in the market made up 19.55% of the total market in 2024. Thermo Fisher Scientific Inc. was the largest competitor with a 3.40% share of the market, followed by Danaher Corporation (Cytia) with 2.38%, Sartorius AG with 2.05%, Lonza Group AG with 2.03%, Merck KGaA (MilliporeSigma), with 1.88%, F. Hoffmann-La Roche Ltd. with 1.81%, Siemens AG with 1.59%, Rockwell Automation Inc. with 1.54%, Emerson Electric Co. with 1.50% and Waters Corporation with 1.37%.
The top opportunities in the bioprocess automation market segmented by component of process control system will arise in the sensors segment, which will gain $2.01 billion of global annual sales by 2030. The top opportunities in the bioprocess automation market segmented by scale of operation will arise in the commercial operations segment, which will gain $3.2 billion of global annual sales by 2030. The top opportunities in the bioprocess automation market segmented by mode of operation will arise in the fed-batch segment, which will gain $2.55 billion of global annual sales by 2030. The top opportunities in the bioprocess automation market segmented by compatibility with bioprocessing systems will arise in the single-use systems segment, which will gain $3.21 billion of global annual sales by 2030. The bioprocess automation market size will gain the most in the USA at $1.86 billion.
Player-adopted strategies in the bioprocess automation market include focuses on expanding their business expertise through strategic partnerships, expanding its operational capabilities through new launches, expanding its operational capabilities through new facilities, enhancing its business operations through new product developments.
Market-trend-based strategies for the bioprocess automation market include focus on integrating artificial intelligence (AI) and machine learning (ML) into bioprocess control systems to enable predictive modelling, automated gradient dispensing, which minimizes manual errors in purification. These systems precisely control the delivery of solvents, leveraging AI-driven technologies and multi-channel biosensing platforms to improve production efficiency, intelligent cell processing system improves production quality and safety and adopting distributed control systems (DCS) to manage complex bioprocessing workflows, enabling centralized supervision.
To take advantage of the opportunities, the analyst recommends the bioprocess automation companies to focus on ai-driven bioprocess control integration, focus on ai-enabled multi-channel biosensing platforms, focus on intelligent closed-loop cell processing systems, focus on high-throughput automated bioprocess development platforms, focus on distributed control systems for integrated bioprocess automation, focus on fastest growing sensors segment in bioprocess automation, focus on preclinical operations in bioprocess automation, focus on perfusion-based continuous bioprocess automation, expand in emerging markets, focus on hybrid distribution networks for bioprocess automation expansion, focus on value based and modular pricing strategies in bioprocess automation, focus on digital first technical promotion and thought leadership, focus on strategic industry partnerships and event driven promotion, focus on single-use systems for scalable bioprocess automation.
This product will be delivered within 3-5 business days.
Table of Contents
1 Executive Summary
6 Market Characteristics
7 Bioprocess Automation Market, Overview of Key Products/Services
8 Bioprocess Automation Market, Supply Chain Analysis
9 Major Market Trends
10 Bioprocess Automation Growth Analysis and Strategic Analysis Framework
11 Global Bioprocess Automation Market Size and Growth Analysis
12 Global Bioprocess Automation Total Addressable Market (TAM) Analysis
13 Global Bioprocess Automation Market Segmentation
14 Bioprocess Automation Market, Regional and Country Analysis
15 Asia-Pacific Market
16 South East Asia Market
17 Western Europe Market
18 Eastern Europe Market
19 North America Market
20 South America Market
21 Middle East Market
22 Africa Market
23 Competitive Landscape and Company Profiles
24 Other Major and Innovative Companies
27 Bioprocess Automation Market - Company Scoring Matrix
29 Key Mergers and Acquisitions
30 Recent Developments in Bioprocess Automation Market
31 Opportunities and Strategies
32 Bioprocess Automation Market, Conclusions and Recommendations
33 Appendix
Executive Summary
Bioprocess Automation Global Market Opportunities and Strategies to 2035 provides the strategists; marketers and senior management with the critical information they need to assess the global bioprocess automation market as it emerges from the COVID-19 shut down.Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Description
Where is the largest and fastest-growing market for bioprocess automation? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The bioprocess automation market global report answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider bioprocess automation market; and compares it with other markets.
The report covers the following chapters
- Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segments, key products, supply chain and market attractiveness scoring and analysis.
- Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future technologies and developments in the market.
- Growth Analysis and Strategic Analysis Framework - Analysis on PESTEL, end use industries, market growth rate, global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
- Global Market Size and Growth: Global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional and Country Analysis: Historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison by region and country.
- Market Segmentation: Contains the market values (2020-2025) (2025-2030, 2035F) and analysis for each segment by component of process control system, by scale of operation, mode of operation and by compatibility with bioprocessing systems in the market. Historic (2020-2025) and forecast (2025-2030) and (2030-2035) market values and growth and market share comparison by region market.
- Regional Market Size and Growth: Regional market size (2025), historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape: Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players
- Other Major and Innovative Companies: Details on the company profiles of other major and innovative companies in the market.
- Competitive Benchmarking: Briefs on the financials comparison between major players in the market.
- Competitive Dashboard: Briefs on competitive dashboard of major players.
- Key Mergers and Acquisitions: Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
- Recent Developments: Information on recent developments in the market covered in the report.
- Market Opportunities and Strategies: Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions and Recommendations: This section includes recommendations for bioprocess automation providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
- Appendix: This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
1) By Component Of Process Control System: Sensors; Actuators; Controllers
2) By Scale Of Operation: Preclinical Operations, Clinical Operations; Commercial Operations
3) By Mode Of Operation: Batch; Fed-Batch; Perfusion
4) By Compatibility With Bioprocessing Systems: Single-Use Systems; Stainless Steel; Other Bioprocessing Systems
Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation (Cytia); Sartorius AG; Lonza Group AG; Merck KGaA (MilliporeSigma)
Countries: China; Australia; India; Indonesia; Japan; South Korea; Taiwan; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; bioprocess automation indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Companies Mentioned
- Thermo Fisher Scientific Inc.
- Danaher Corporation (Cytia)
- Sartorius AG
- Lonza Group AG
- Merck KGaA (MilliporeSigma)
- F. Hoffmann-La Roche Ltd.
- Siemens AG
- Rockwell Automation Inc.
- Emerson Electric Co.
- Waters Corporation
- WuXi Biologics
- Sino-Biocan (Shanghai) Biotech Ltd.
- Körber AG
- Bailun Biotechnology Co., Ltd.
- Shanghai Baoxing Bio-Engineering Equipment (BXBIO)
- MIKEBIO (Jiangsu Mike Biotechnology)
- Jichen Bio
- Nanjing BioWill Biological Engineering
- TIANGEN Biotech (TEasy lab automation)
- Marubishi Bioengineering Co. Ltd.
- BIOTEC Co., Ltd.
- Yokogawa Electric Corporation
- ABB Robotics
- Ajinomoto Co. Inc.
- Micro Digital Co.
- BioSystemENG Co. Ltd.
- Biostream Co. Ltd.
- Leadgene Biosolutions Co., Ltd.
- Mycenax Biotech Inc.
- Amaran Biotechnology Inc.
- AstraZeneca
- Eppendorf SE
- Syntegon
- Solaris Biotech
- BIONET
- Parker-Hannifin Corporation
- Infors AG
- DISTek Integration
- SyVento Biotech
- ILS Automation LLC
- Curi Bio, Inc.
- Repligen Corporation
- Flotek Industries Inc.
- Automated Control Concepts Inc.
- Flownamics Analytical Instruments Inc.
- Beckman Coulter Life Sciences
- Molecular Devices
- Nirrin Technologies
- New Wave Biotech
- Bio-Rad Laboratories, Inc.
- Pall Corporation
- Bruker Corporation
- ATS Life Sciences
- Everest Automation
- Amgen
- Pharmaconex
- Anasia Process Automation
- INTECH Process Automation Nigeria LTD
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 391 |
| Published | June 2026 |
| Forecast Period | 2025 - 2035 |
| Estimated Market Value ( USD | $ 6.36 Billion |
| Forecasted Market Value ( USD | $ 20.24 Billion |
| Compound Annual Growth Rate | 12.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 58 |
